Advertisement

Clinical and Translational Oncology

, Volume 20, Issue 11, pp 1392–1399 | Cite as

The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables

  • P. Jimenez-Fonseca
  • C. Calderon
  • A. Carmona-Bayonas
  • M. M. Muñoz
  • R. Hernández
  • M. Mut Lloret
  • I. Ghanem
  • C. Beato
  • D. Cacho Lavín
  • A. Ivars Rubio
  • R. Carrión
  • C. Jara
Research Article

Abstract

Purpose

The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients’ emotional distress, and coping in subjects with resected, non-metastatic cancer.

Methods

602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants’ emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires.

Results

Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I–II (28 vs 18%).

Conclusion

Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients.

Keywords

Cancer Coping Distress Medical oncologist Satisfaction Shared decision-making 

Notes

Funding

The study was supported by the FSEOM-Onvida for Projects on Long Survivors and Quality of Life. SEOM (Spanish Society of Medical Oncology) 2015.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest. This is an academic study.

Ethical approval

The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. This study is an observational trial without intervention.

Informed consent

Signed informed consent was obtained from all patients.

References

  1. 1.
    Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRefGoogle Scholar
  2. 2.
    Travado L, Reis JC, Watson M, Borràs J. Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC). Psychooncology. 2017;530:523–30.CrossRefGoogle Scholar
  3. 3.
    Grassi L, Berardi MA, Ruffilli F, Meggiolaro E, Andritsch E, Sirgo A, et al. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom. 2015;84:339–47.CrossRefGoogle Scholar
  4. 4.
    Grassi L, Travado L, Moncayo FLG, Sabato S, Rossi E. Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Disord. 2004;83:243–8.CrossRefGoogle Scholar
  5. 5.
    Faller H, Weis J, Koch U, Brähler E, Härter M, Keller M, et al. Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res. 2016;81:24–30.CrossRefPubMedGoogle Scholar
  6. 6.
    Ross L, Petersen MA, Johnsen AT, Lundstrøm LH, Groenvold M. Cancer patients’ evaluation of communication: a report from the population-based study ‘The Cancer Patient’s World’. Support Care Cancer. 2013;21:235–44.CrossRefGoogle Scholar
  7. 7.
    Mathews M, Ryan D, Bulman D. What does satisfaction with wait times mean to cancer patients? BMC Cancer. 2015;15:1017.CrossRefPubMedGoogle Scholar
  8. 8.
    De Vries AMM, Roten Y, Meystre C, Passchier J, Despland J, Stiefel F. Clinician characteristics, communication, and patient outcome in oncology: a systematic review. Psycho-Oncology. 2014;23:375–81.CrossRefGoogle Scholar
  9. 9.
    Gilbar O, Zusman A. The correlation between coping strategies, doctor–patient/spouse relationships and psychological distress among women cancer patients and their spouses. Psycho-Oncology. 2007;16:1010–8.CrossRefGoogle Scholar
  10. 10.
    Blanch-Hartigan D, Chawla N, Beckjord EI, Forsythe LP, de Moor JS, Hesse BW, et al. Cancer survivors’ receipt of treatment summaries and implications for patient-centered communication and quality of care. Patient Educ. 2015;98:1274–9.CrossRefGoogle Scholar
  11. 11.
    Scholl I, Kriston L, Dirmaier J, Buchholz A, Härter M. Development and psychometric properties of the Shared Decision Making Questionnaire—physician version (SDM-Q-Doc). Patient Educ Couns. 2012;88:284–90.CrossRefGoogle Scholar
  12. 12.
    Calderon C, Ferrando PJ, Carmona-Bayonas A, Lorenzo-Seva U, Jara C, Beato C, et al. Validation of SDM-Q-Doc Questionnaire to measure shared decision-making physician’s perspective in oncology practice. Clin Transl Oncol. 2017;19:1–8.CrossRefGoogle Scholar
  13. 13.
    Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010;80:94–9.CrossRefGoogle Scholar
  14. 14.
    De las Cuevas C, Perestelo-Perez L, Rivero-Santana A, Cebolla-Martí A, Scholl I, Härter M. Validation of the Spanish version of the 9-item Shared Decision-Making Questionnaire. Health Expect. 2015;18:2143–53.CrossRefGoogle Scholar
  15. 15.
    Simon D, Schorr G, Wirtz M, Vodermaier A, Caspari C, Neuner B, et al. Development and first validation of the shared decision-making questionnaire (SDM-Q). Patient Educ Couns. 2006;63:319–27.CrossRefGoogle Scholar
  16. 16.
    Watson M, Law MG, dos Santos M, Greer S, Baruch J, Bliss J. The Mini-MAC. J Psychosoc Oncol. 1994;12:33–46.CrossRefGoogle Scholar
  17. 17.
    Anagnostopoulos F, Kolokotroni P, Spanea E, Chryssochoou M. The Mini-Mental Adjustment to Cancer (Mini-MAC) scale: construct validation with a Greek sample of breast cancer patients. Psycho-Oncology. 2006;15:79–89.CrossRefGoogle Scholar
  18. 18.
    Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464–88.CrossRefPubMedGoogle Scholar
  19. 19.
    Derogatis LR. BSI 18, Brief Symptom Inventory 18: administration, scoring and procedures manual. Minneapolis: NCS Pearson, Inc.; 2001.Google Scholar
  20. 20.
    Andreu Y, Galdón MJ, Dura E, Ferrando M, Murgui S, García A, et al. Psychometric properties of the Brief Symptoms Inventory-18 (BSI-18) in a Spanish sample of outpatients with psychiatric disorders. Psicothema. 2008;20:844–50.Google Scholar
  21. 21.
    Martín-Fernández R, Abt-Sacks A, Perestelo-Perez L, Serrano-Aguilar P. Shared decision making in breast cancer womens’ attitudes. Rev Esp Salud Publica. 2013;87:59–72.CrossRefGoogle Scholar
  22. 22.
    Padilla-Garrido N, Correa FA, Moreno MO, Calero JB, Lozano EB. La toma de decisiones compartidas desde la perspectiva del paciente oncológico: roles de participación y valoración del proceso. An Sist Sanit Navar. 2017;40:25–33.Google Scholar
  23. 23.
    Meggiolaro E, Berardi MA, Andritsch E, et al. Cancer patients’ emotional distress, coping styles and perception of doctor–patient interaction in European cancer settings. Palliat Support Care. 2016;14:204–11.CrossRefGoogle Scholar
  24. 24.
    Jansen L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants and associations with quality of life. Br J Cancer. 2011;105:1158–65.CrossRefPubMedGoogle Scholar
  25. 25.
    Nenova M, DuHamel K, Zemon V, Rini C, Redd WH. Posttraumatic growth, social support, and social constraint in hematopoietic stem cell transplant survivors. Psychooncology. 2013;22:195–202.CrossRefGoogle Scholar
  26. 26.
    Yi J, Kim MA. Postcancer experiences of childhood cancer survivors: how is posttraumatic stress related to posttraumatic growth? J Trauma Stress. 2014;27:461–7.CrossRefGoogle Scholar
  27. 27.
    McDonough MH, Sabiston CM, Wrosch C. Predicting changes in posttraumatic growth and subjective well-being among breast cancer survivors: the role of social support and stress. Psychooncology. 2014;23:114–20.  https://doi.org/10.1002/pon.3380.CrossRefGoogle Scholar
  28. 28.
    Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol. 2012;30:1151–3.CrossRefGoogle Scholar
  29. 29.
    Lang M, Giese-Davis J, Patten S, Campbell DJT. Does age matter? Comparing post-treatment psychosocial outcomes in young adult and older adult cancer survivors with their cancer-free peers. Psycho-Oncology. 2017  https://doi.org/10.1002/pon.4490.CrossRefGoogle Scholar
  30. 30.
    Quinn GP, Gonçalves V, Sehovic I, Bowman ML, Reed DR. Quality of life in adolescent and young adult cancer patients: a systematic review of the literature. Patient Relat Outcome Meas. 2015;6:19–51.CrossRefPubMedGoogle Scholar
  31. 31.
    Ng CG, Mohamed S, Kaur K, Sulaiman AH, Zainal NZ, Taib NA, et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One. 2017;12:e0172975.CrossRefPubMedGoogle Scholar
  32. 32.
    Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141:343–51.CrossRefPubMedGoogle Scholar
  33. 33.
    Thorne S, Hislop TG, Kim-Sing C, Oglov V, Oliffe JL, Stajduhar KI. Changing communication needs and preferences across the cancer care trajectory: insights from the patient perspective. Support Care Cancer. 2014;22:1009–15.CrossRefGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2018

Authors and Affiliations

  • P. Jimenez-Fonseca
    • 1
  • C. Calderon
    • 2
  • A. Carmona-Bayonas
    • 3
  • M. M. Muñoz
    • 4
  • R. Hernández
    • 5
  • M. Mut Lloret
    • 6
  • I. Ghanem
    • 7
  • C. Beato
    • 8
  • D. Cacho Lavín
    • 9
  • A. Ivars Rubio
    • 3
  • R. Carrión
    • 10
  • C. Jara
    • 11
  1. 1.Department of Medical OncologyHospital Universitario Central de AsturiasOviedoSpain
  2. 2.Department of Clinical Psychology and Psychobiology, Faculty of PsychologyUniversity of BarcelonaBarcelonaSpain
  3. 3.Department of Hematology and Medical OncologyHospital Universitario Morales MeseguerMurciaSpain
  4. 4.Department of Medical OncologyHospital Virgen de La LuzCuencaSpain
  5. 5.Department of Medical OncologyHospital Universitario de CanariasTenerifeSpain
  6. 6.Department of Medical OncologyHospital Universitario Son EspasesMallorcaSpain
  7. 7.Department of Medical OncologyHospital Universitario La PazMadridSpain
  8. 8.Department of Medical OncologyHospital Universitario Virgen de La MacarenaSevillaSpain
  9. 9.Department of Medical OncologyHospital Universitario Marqués de ValdecillaSantanderSpain
  10. 10.Department of Medical OncologyHospital Universitario del SuresteArganda del ReySpain
  11. 11.Department of Medical Oncology, Hospital Universitario Fundación AlcorcónUniversidad Rey Juan CarlosMadridSpain

Personalised recommendations